A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese haemodialysis patients

BACKGROUND: Secondary hyperparathyroidism (SHPT) is a major complication associated with chronic kidney disease. We evaluated the efficacy and safety of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, in Japanese haemodialysis patients with SHPT. METHODS: In this phase 3, multice...

全面介紹

Na minha lista:
書目詳細資料
發表在:Nephrol Dial Transplant
Main Authors: Fukagawa, Masafumi, Yokoyama, Keitaro, Shigematsu, Takashi, Akiba, Takashi, Fujii, Akifumi, Kuramoto, Takuto, Odani, Motoi, Akizawa, Tadao
格式: Artigo
語言:Inglês
出版: Oxford University Press 2017
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837215/
https://ncbi.nlm.nih.gov/pubmed/28057872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw408
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍